Skip to content

13F-HR filed by Deep Track Capital, LP

Deep Track Capital, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 13:55:03 UTC, with 74 holding rows worth $6,138,977,076.

Accession
0001856083-26-000006
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 74 entries on the cover page, a total value of $6,138,977,076 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,138,977,076 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GUARDANT HEALTH INC COM40131M109Stock2,805,677$500,420,550dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM6,374,395$382,463,700dollars as filed
IMMUNOVANT INC45258J102COM9,160,801$309,451,858dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK3,806,768$299,250,032dollars as filed
VERADERMICS INC922967104COMMON STOCK1,900,000$230,337,000dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK7,000,000$226,030,000dollars as filed
VAXCYTE INC COM92243G108Stock3,513,069$199,893,626dollars as filed
ALKERMES PLCG01767105SHS4,500,000$182,340,000dollars as filed
OCULAR THERAPEUTIX INC67576A100COM21,939,625$168,276,924dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock300,040$162,588,676dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY5,000,000$156,350,000dollars as filed
GRAIL INC384747101COM1,104,200$154,720,504dollars as filed
INSMED INC COM PAR $.01457669307Stock1,350,000$154,089,000dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS12,161,496$151,289,010dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share4,182,689$149,217,430dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock800,000$147,512,000dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK6,000,000$142,260,000dollars as filed
LB PHARMACEUTICALS INC50180M108COMMON STOCK3,352,804$128,680,617dollars as filed
TANGO THERAPEUTICS INC87583X109COM4,500,000$112,275,000dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock4,083,969$111,002,277dollars as filed
HEMAB THERAPEUTICS HLDGS INC423494103COM SHS3,587,796$110,647,629dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share2,760,000$98,463,000dollars as filedcall
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock8,105,290$94,831,893dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock1,069,774$89,101,476dollars as filed
GENEDX HOLDINGS CORP81663L200COM CL A1,200,000$86,760,000dollars as filed
TEMPUS AI INC CL A88023B103Stock1,000,000$81,900,000dollars as filedcall
COGENT BIOSCIENCES INC19240Q201COM2,500,000$80,050,000dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock3,333,334$78,266,682dollars as filed
BICARA THERAPEUTICS INC055477103COM4,100,000$76,301,000dollars as filed
Latigo Biotherapeutics, Inc.517954103Common Stock, par value $0.0001 per share4,408,322$73,618,978dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW2,125,532$68,888,492dollars as filed
BRIDGEBIO PHARMA INC10806X102COM885,882$58,291,036dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK3,610,000$55,341,300dollars as filed
ALUMIS INC022307102COM7,469,746$55,201,423dollars as filed
ALTIMMUNE INC02155H200COM NEW19,250,000$55,055,000dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM3,207,138$54,970,345dollars as filed
BILLIONTOONE INC090168105CL A500,000$53,220,000dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock9,345,000$49,154,700dollars as filed
CORMEDIX INC COM21900C308Stock6,274,076$48,310,385dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM1,148,817$46,641,970dollars as filed
VERASTEM INC92337C203COMMON STOCK5,740,850$46,213,843dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS1,000,000$38,060,000dollars as filed
GENERATE BIOMEDICINES INC370920100COMMON STOCK2,507,449$37,661,884dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock640,000$37,516,800dollars as filed
ANI PHARMACEUTICALS INC00182C103COM500,000$36,325,000dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM1,711,030$35,230,108dollars as filed
HARROW INC415858109COM1,069,000$32,925,200dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share2,120,050$29,108,287dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM2,491,939$28,707,137dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM200,000$28,368,000dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK3,565,062$25,775,398dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK3,706,734$25,279,926dollars as filed
BEAM THERAPEUTICS INC07373V105COM1,000,000$24,450,000dollars as filed
MANNKIND CORP COM NEW56400P706Stock5,030,522$19,619,036dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock500,000$18,595,000dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM2,109,951$18,229,977dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK300,000$18,163,500dollars as filed
DESIGN THERAPEUTICS INC25056L103COM1,323,986$16,642,504dollars as filed
CENTURY THERAPEUTICS INC15673T100COM9,462,645$16,181,123dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock1,000,000$16,110,000dollars as filedcall
XENCOR INC98401F105COMMON STOCK540,000$13,473,000dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK1,318,101$13,431,449dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM1,000,000$13,180,000dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK4,501,684$13,054,884dollars as filed
KARDIGAN INC485925101CMN600,000$8,850,000dollars as filed
PROMIS NEUROSCIENCES INC74346M505COM SHS740,117$8,030,269dollars as filed
ENTERA BIO LTDM40527109SHS2,450,980$7,132,352dollars as filed
RXSIGHT INC78349D107COM1,230,566$6,029,773dollars as filed
RAINIER ACQUISITION CORPG73591110UNIT500,000$5,100,000dollars as filed
JATT III ACQUISITION CORPG5080G109COM450,000$4,959,000dollars as filed
RESEARCH ALLIANCE CORP IVG75228109CL A ORD SHS400,000$4,628,000dollars as filed
TCGX ACQUISITION CORPG8708J109COM300,000$3,753,000dollars as filed
ALIGOS THERAPEUTICS INC01626L204COM NEW444,110$2,500,339dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM7,419,355$2,228,774dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001856083-26-000006this filing2026-11-16